Early research (Phase 1)Study completedNCT00938899
What this trial is testing
TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing
Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 55